14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CL vs BUD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Anheuser-Busch INBEV SA/NV (BUD) is the stronger overall head-to-head candidate over Colgate-Palmolive Company (CL) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CL carries a Unified Composite Score of 33.9/100 (SELL) at $101.47 (24.3x Forward P/E, 20.7% operating margin), whereas BUD carries 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin).
Defensive Composite Rating Caution: Although BUD compares more favorably head-to-head, both CL (33.9/100 SELL) and BUD (34.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CL vs BUD. Trailing 12-month operating profitability (CL 20.7% vs BUD 26.7%) and valuation multiples (CL 24.3x vs BUD 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Household & Personal Products value chain with $77.8B market capitalization and 20.7% operating margin.
OpEx & R&D Reinvestment39.9% of Rev ($8.49B)
90D Engineering Disclosures0 Published
BUD Moat ProfileScale & Operating Efficiency Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $167.3B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment29.8% of Rev ($19.1B)
90D Engineering Disclosures0 Published
Investor FAQ CL vs BUD Key Questions & Quantitative Answers
As of Nov 16, 2026, Anheuser-Busch INBEV SA/NV (BUD) is the stronger overall head-to-head candidate over Colgate-Palmolive Company (CL) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CL carries a Unified Composite Score of 33.9/100 (SELL) at $101.47 (24.3x Forward P/E, 20.7% operating margin), whereas BUD carries 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin). Defensive Composite Rating Caution: Although BUD compares more favorably head-to-head, both CL (33.9/100 SELL) and BUD (34.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
BUD leads the Growth & Scale pillar: CL posts +4.6% YoY revenue growth and +3.3% YoY earnings growth on $21.3B TTM revenue (60.6% gross margin, 20.7% operating margin), compared with BUD at +9.1% YoY revenue growth and +52.5% YoY earnings growth on $64.0B TTM revenue (56.5% gross margin, 26.7% operating margin). On trailing 12-month operating scale, CL generates $21.3B in USD-normalized revenue versus $64.0B for BUD. In operating R&D and SG&A reinvestment, CL deploys 39.9% of Rev ($8.49B) (0 90-day corporate R&D disclosures) versus 29.8% of Rev ($19.1B) (0 disclosures) for BUD.
BUD screens cheaper on headline valuation multiples. CL trades at 24.3x Forward P/E, 38.1x Trailing P/E, 1.79x PEG, and 3.9x EV/Revenue (17.8% FCF margin), whereas BUD trades at 17.4x Forward P/E, 17.3x Trailing P/E, 1.74x PEG, and 2.6x EV/Revenue (31.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CL (231.7% ROE) versus BUD (11.4% ROE) capital efficiency.
In options market volatility and institutional positioning, CL carries 24.3% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.44x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.03β · 30% Vol realized risk). By comparison, BUD carries 23.6% implied volatility (42nd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 33% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.